Read about #NIDA Director Dr. Nora Volkow's 🆕 guest editorial for American Society of Addiction Medicine - ASAM: To address the fentanyl crisis, greater access to methadone is needed. In the blog, Dr. Volkow discusses why methadone should be made more accessible to people with an opioid use disorder, citing growing evidence that suggests methadone is as safe and effective as buprenorphine for patients who use fentanyl.
The National Institute on Drug Abuse (NIDA)
Research Services
North Bethesda, Maryland 80,192 followers
Comment Policy: https://nida.nih.gov/comment-policy
About us
Official LinkedIn page of The National Institute on Drug Abuse. NIDA's mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health. Engagement ≠ Endorsement Comment Policy: https://nida.nih.gov/comment-policy Privacy Policy: https://nida.nih.gov/privacy/how-nida-uses-third-party-web-sites-applications
- Website
-
https://nida.nih.gov/
External link for The National Institute on Drug Abuse (NIDA)
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- North Bethesda, Maryland
- Type
- Government Agency
- Founded
- 1974
- Specialties
- Addiction Research, Research Training, and Research Funding
Locations
-
Primary
Three White Flint North
11601 Landsdown Street
North Bethesda, Maryland 20892, US
-
251 Bayview Boulevard
Baltimore, MD 21224, US
Employees at The National Institute on Drug Abuse (NIDA)
Updates
-
🆕 #NIDA-supported research in 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘐𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘶𝘴 𝘋𝘪𝘴𝘦𝘢𝘴𝘦𝘴: Illicit fentanyl use and hepatitis c virus seroconversion among people who inject drugs in Tijuana and San Diego: Results from a binational cohort study. Infectious Diseases Society of America UC San Diego https://loom.ly/NdoDlNw
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study
academic.oup.com
-
🆕 #NIDA-funded research in 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘎𝘦𝘯𝘦𝘳𝘢𝘭 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘭 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦: A longitudinal multivariable analysis: State policies and opioid dispensing in Medicare beneficiaries undergoing surgery. Society of General Internal Medicine (SGIM) RAND https://loom.ly/nI5z340
A Longitudinal Multivariable Analysis: State Policies and Opioid Dispensing in Medicare Beneficiaries Undergoing Surgery - Journal of General Internal Medicine
-
Using #MonitoringTheFuture data, 🆕 #NIDA-supported research letter in JAMA: Adolescent use, diversion sources, and perceived procurement difficulty of prescription medications. University of Michigan Massachusetts General Hospital Texas State University https://lnkd.in/gFPeNdzy
Between 2009 and 2022, US adolescents reported declines in medical use and nonmedical use of prescription medications, concurring with other research. https://ja.ma/4fenV9P
-
-
🆕 from #NIDA Director Dr. Nora Volkow & colleagues in 𝘈𝘯𝘯𝘢𝘭𝘴 𝘰𝘧 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘭 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦: Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes. Authors say, semaglutide was associated with lower risks for tobacco use disorder-related health care measures in patients with comorbid type 2 diabetes and tobacco use disorder compared with other antidiabetes medications including other glucagon-like peptide receptor agonists, primarily within 30 days of prescription. https://loom.ly/kAaAeq0
Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data: Annals of Internal Medicine: Vol 0, No 0
acpjournals.org
-
In case you missed it: The FDA has granted U.S. market authorization for the first rapid hepatitis C virus test that can be used in patient care settings and deliver results in about one hour. The new technology – validated through a collaboration between RADx Tech at The National Institutes of Health, FDA and Centers for Disease Control and Prevention – could help patients with positive tests begin treatment right away. Read more: https://loom.ly/NSaC5Cg #Hepatitis #MedTech #Diagnostics
-
-
#NIDA's Director Dr. Nora Volkow and Case Western Reserve University's Dr. Rong Xu co-authored a 🆕 editorial in 𝘈𝘥𝘥𝘪𝘤𝘵𝘪𝘰𝘯 𝘑𝘰𝘶𝘳𝘯𝘢𝘭: GLP-1R Agonist Medications for Addition Treatment. Authors say, closing the addiction treatment gap and discovering new, more effective addiction medications are urgent priorities. In this regard investigating the potential of GLP-1 analogue medications to treat substance use disorders deserve fast and rigorous testing. https://loom.ly/CZoEvkM
GLP‐1R agonist medications for addiction treatment
onlinelibrary.wiley.com
-
🆕 from #NIDA & colleagues in The Journal of Clinical Psychiatry: Prescription opioid use disorder among adults reporting prescription opioid use with or without misuse in the United States. Authors say, moderate-to-severe prescription opioid use disorder is more frequent among adults who report misusing prescription opioids. However, 62% of adults with prescription opioid use disorder do not report prescription opioid misuse, suggesting that adults who are treated with prescription opioids and report no misuse could be at risk for developing prescription opioid use disorder. Read more: https://loom.ly/okcjkvE Substance Abuse and Mental Health Services Administration (SAMHSA) Centers for Disease Control and Prevention
Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use
https://www.psychiatrist.com
-
The National Institute on Drug Abuse (NIDA) reposted this
NIH is taking steps to re-envision the postdoctoral training experience, but the feedback of the biomedical research community is a crucial part of this process. Among the actions under consideration are: ➡️Limiting the amount of time a postdoctoral scholar can be supported by NIH funds to five years to speed transition into research careers. ➡️ Shorten the eligibility window and refocus review criteria for a key mentored career development award (K99/R00) to facilitate more rapid transition of postdoctoral scholars. ➡️Enhancing training and professional development for postdoctoral scholars and their mentors. Share your feedback by October 23, 2024: https://go.nih.gov/amqQ7DD
-
-
The NIH HEAL Initiative® seeks input on future research priorities and how scientific research can continue to address the urgent public health challenges of opioid use disorder, overdose, and pain. Your feedback will help inform HEAL research! Please send an email to [email protected] with “HEAL RFI” in the subject line by July 31, 2024. #nihHEALinitiative #RFI Learn more: go.nih.gov/mcoqY3J
-